NIH-funded research R21 grant

Understanding how herpes simplex virus type 1 changes its DNA during infection

Official title: Modulation of herpes simplex virus type 1 genome structure during lytic replication

Funded at Duquesne University · NIH-10495222 · Data updated 2026-11-12

This study is looking at how the herpes virus changes its DNA while it’s inside our cells, with the goal of finding new ways to understand how it works and affects people, so we can improve treatments for those with HSV-1.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionDuquesne University
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 24, 2021
Project endAugust 31, 2025
Funding year2022
Award (this year)$207,000
NIH project number5R21AI166879-02
Project IDNIH-10495222 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are infected with herpes simplex virus type 1 or are at risk of infection.

Less likely to help

Patients who do not have herpes simplex virus type 1 or are not at risk of infection may not benefit from this research.

What this research studies

This research investigates the herpes simplex virus type 1 (HSV-1), a common virus that affects many people. It focuses on how the virus's DNA structure changes during its life cycle inside human cells, particularly in the nucleus where the virus replicates. The researchers aim to develop new methods to map the DNA structure of HSV-1 and understand how it interacts with the host's cellular machinery during infection. By studying these processes, the research seeks to uncover the mechanisms that influence the outcome of HSV-1 infections.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating or preventing infections caused by herpes simplex virus type 1.

How similar studies have gone: While there has been some research on viral DNA structure, this approach to mapping the HSV-1 genome during infection is relatively novel and has not been extensively tested.

Where this research is happening

  • Duquesne University
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Dembowski, Jill Ann — Duquesne University
  • Study coordinator: Dembowski, Jill Ann

Related research

Other NIH-funded projects on the same topics.

  • Genes essential for egg function and fertilization

    Researchers are studying how eggs become ready to fertilize and trigger embryo development, using a worm model to uncover key egg-side Molecules that could inform fertility and birth control research for adults.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11619389

  • Systemic travel of damaged DNA in autoimmune skin disorders

    A research project looks at tiny particles shed from UV-damaged skin that carry damaged DNA and travel through the body, potentially worsening autoimmune inflammation in people with photosensitive conditions like lupus.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11537827

  • Injectable 3D Tissues to Support Regulatory T Cells for Better Allograft Tolerance

    This grant explores a new injectable 3D cell therapy approach to help regulate the immune system and reduce transplant rejection in people who receive organ transplants.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11350997

  • Mosquito bacteria designed to block malaria spread

    Researchers are modifying harmless bacteria inside mosquitoes so the bugs can't pass malaria to people.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11323096

  • How human cell proteins help herpes simplex virus copy and repair its DNA

    The team is identifying how human cell proteins interact with herpes simplex virus DNA during copying, repair, and gene activation to guide future treatments for people with HSV infections.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11261202

  • Restoring the brain's cleanup cells to help in Lewy body disease

    This project looks at whether removing and then regrowing the brain's immune cells can help clear harmful protein clumps that damage people with Lewy body disease.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11194408

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.